Skip to main content
MedPathMedPath Home
Clinical Trials/DRKS00022091
DRKS00022091
Recruiting
Not Applicable

Blood brain barrier permeability and inflammatory biomarkers in patients with depression - DEFLAME

Klinik für Psychiatrie, Psychosomatik und PsychotherapieUniversitätsklinikum Frankfurt0 sites100 target enrollmentJuly 6, 2023
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsF32.2F32.3F33.2F33.3Severe depressive episode without psychotic symptomsSevere depressive episode with psychotic symptomsRecurrent depressive disorder, current episode severe without psychotic symptomsRecurrent depressive disorder, current episode severe with psychotic symptoms

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
F32.2
Sponsor
Klinik für Psychiatrie, Psychosomatik und PsychotherapieUniversitätsklinikum Frankfurt
Enrollment
100
Status
Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 6, 2023
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Klinik für Psychiatrie, Psychosomatik und PsychotherapieUniversitätsklinikum Frankfurt

Eligibility Criteria

Inclusion Criteria

  • •\- Presence of a severe single or recurrent depressive disorder with or without psychotic symptoms (according to ICD 10: F32\.2, F32\.3, F33\.2, F33\.3\)
  • •\- ability to give consent
  • •Healthy controls:
  • •\- Ability to give consent

Exclusion Criteria

  • •\- Presence of a severe somatic or neurological disease
  • •\- Pregnancy and breastfeeding
  • •Healthy controls:
  • •\- Presence of a psychiatric, severe somatic or neurological disease
  • •\- Pregnancy and breastfeeding

Outcomes

Primary Outcomes

Not specified

Similar Trials

Active, not recruiting
Not Applicable
Permeability of the blood-brain barrier in Alzheimer’s disease
ISRCTN17419165niversity of Southampton70
Recruiting
Not Applicable
Quantitative blood-brain barrier permeability and susceptibility mapping for patients with CADASIL and suspected to have CADASICADASI
JPRN-UMIN000035081agoya City University40
Recruiting
Not Applicable
Blood-brain barrier permeability and cerebral perfusion in Alzheimer*s diseaseneurodegeneratieve aandoeningenAlzheimer's diseasedementia
NL-OMON38302niversiteit Maastricht60
Active, not recruiting
Not Applicable
Studies on Permeability of the Blood-Brain-Barrier for Escitaloprame related to various Genotypes of the ABCB1-Gene: Effects on Sleep and Motoric Learning - Escitaloprame, sleep, blood-brain-barrierEffects on sleep electroencephalogram and motoric learning in healthy volunteers related to the permeability of the blood-brain-barrier related to genotypes of the ABCB 1 gene
EUCTR2006-001491-21-DEMax Planck Institute of Psychiatry58
Completed
Not Applicable
Blood-Brain Barrier permeability quantification in cerebral small vessel disease -- reproducibility of dynamic contrast-enhanced MRICerebral small vessel diseasedisease of the small brain arteries10007963
NL-OMON38519Medisch Universitair Ziekenhuis Maastricht20